Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_assertion type Assertion NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_head.
- NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_assertion description "[The preclinical mutation carrier group 2 scored significantly higher than the nonmutation carrier group for 3 of the SCL-90-R symptom dimensions (anxiety, paranoid ideation, and psychoticism).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_provenance.
- NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_assertion evidence source_evidence_literature NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_provenance.
- NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_assertion SIO_000772 17210818 NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_provenance.
- NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_assertion wasDerivedFrom befree-20150227 NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_provenance.
- NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_assertion wasGeneratedBy ECO_0000203 NP528705.RAUYR6M5jHwMYV-A7namzhQjJfzR-MYZVbQ9crs4QtspA130_provenance.